Background: Heart failure (HF) and atrial fibrillation (AF) are twin epidemics with poor prognosis in pts with type 2 diabetes mellitus (T2DM). Obstructive sleep apnea (OSA) is an important correlate of T2DM, but its role in HF+AF is unclear, as is the role of underlying lung disease. We sought to evaluate clinical predictors of new HF and AF in T2DM.
Methods: 914 consecutive T2DM pts (age 56±11y) without prior HF or AF and with a negative stress echo were enrolled in an observational study, after exclusion of prior cardiac surgery, > mild valvular heart disease, or ejection fraction < 50%. Demographics, clinical assessments based on standards of diabetes care, co-morbidities, and treatment with insulin, diuretics, beta-blockers, statins, ace-inhibitors and aspirin were collected at the time of stress echo. Pts were followed for up to 8 y for HF+AF, and best predictors of endpoints were sought by using nested Cox proportional hazard models.
Results: 22 new HF and 25 new AF developed during a mean time of 4.8 y. OSA and asthma were associated with outcome in univariate and all adjusted models (Table) , independent of socio-economic class, diabetes care and clinical predictors.
Conclusion:
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